Nakazato-Imasato Etsuko, Kurebayashi Yoichi
Life Sci. 2009 Apr 24;84(17-18):622-6.
We examined the possible involvement of spontaneous on-going pain in the rat chronic constriction injury (CCI) model of neuropathic pain.
The development of weight bearing deficit, as an index of spontaneous on-going pain, was investigated in comparison to that of mechanical allodynia in CCI rats. We also examined the effects of morphine and a gabapentin analogue (1S, 3R)-3-methyl-gabapentin (3-M-gabapentin) on both the CCI-induced weight bearing deficit and mechanical allodynia.
Rats with CCI demonstrated a significant reduction in weight bearing of the injured limb with a peak at a week post-operation, which was followed by a gradual recovery for over 7 weeks. The time course of development and recovery of CCI-induced weight bearing deficit appeared to follow that of foot deformation of the affected hind limb. CCI also evoked mechanical allodynia that was fully developed on a week post-operation, but showed no recovery for at least 8 weeks. 3-M-gabapentin significantly inhibited CCI-induced mechanical allodynia, but not weight bearing deficit, at 100 mg/kg p.o. Likewise, morphine was without significant effect on CCI-induced weight bearing deficit at the dose (3 mg/kg, s.c.) that could almost completely inhibit mechanical allodynia, whereas it inhibited both mechanical allodynia and weight bearing deficit at 6 mg/kg, s.c.
The present findings suggest that CCI-induced weight bearing deficit is not a consequence of mechanical allodynia, but is attributable to spontaneous on-going pain. The rat CCI model of neuropathic pain thus represents both spontaneous on-going pain and mechanical allodynia.
我们研究了在大鼠神经性疼痛的慢性压迫损伤(CCI)模型中,持续性自发痛可能发挥的作用。
以负重缺陷的发展作为持续性自发痛的指标,与CCI大鼠的机械性异常性疼痛进行比较研究。我们还研究了吗啡和加巴喷丁类似物(1S,3R)-3-甲基-加巴喷丁(3-M-加巴喷丁)对CCI诱导的负重缺陷和机械性异常性疼痛的影响。
CCI大鼠受伤肢体的负重显著降低,在术后一周达到峰值,随后在7周多的时间里逐渐恢复。CCI诱导的负重缺陷的发展和恢复的时间进程似乎与受影响后肢的足部变形一致。CCI还诱发了机械性异常性疼痛,在术后一周完全出现,但至少8周没有恢复。3-M-加巴喷丁在口服100mg/kg时能显著抑制CCI诱导的机械性异常性疼痛,但对负重缺陷无影响。同样,吗啡在剂量为3mg/kg(皮下注射)时,几乎能完全抑制机械性异常性疼痛,但对CCI诱导的负重缺陷无显著影响,而在剂量为6mg/kg(皮下注射)时,它既能抑制机械性异常性疼痛,也能抑制负重缺陷。
目前的研究结果表明,CCI诱导的负重缺陷不是机械性异常性疼痛的结果,而是由持续性自发痛引起的。因此,大鼠神经性疼痛的CCI模型同时代表了持续性自发痛和机械性异常性疼痛。